News
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
26mon MSN
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
Asianet Newsable on MSN44m
Eli Lilly, Novo Nordisk Shares Rally As Trump Administration Reportedly Plans To Experiment Including Weight-loss Drugs Under Medicaid, MedicareThe Washington Post reported on Friday that state Medicaid programs and Medicare Part D insurance plans will be able to ...
Shares in European pharmaceutical firms slumped on Friday following a threat by President Donald Trump to punish them if they don't lower prices for medicines in the United States.
Though the Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq Composite Index (IXIC) all posted strong monthly gains on Thursday, they're all headed for firm weekly losses. The Dow is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback